SERUM AMINOTRANSFERASE LEVELS AS AN INDICATOR OF THE EFFECTIVENESS OF VENESECTION FOR CHRONIC HEPATITIS-C

被引:55
作者
HAYASHI, H [1 ]
TAKIKAWA, T [1 ]
NISHIMURA, N [1 ]
YANO, M [1 ]
机构
[1] NAGOYA UNIV, SCH MED, DEPT MED 3, NAGOYA, AICHI 466, JAPAN
关键词
CYTOTOXICITY; FREE RADICAL; IRON; TREATMENT;
D O I
10.1016/0168-8278(95)80278-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Iron cytotoxicity may play an important role in chronic hepatitis C, The effects of venesection suggest that a slight iron overload contributes to hepatic injury in subjects infected with hepatitis C virus, A better indication of the efficacy of venesection was studied in patients with and without overt iron overloading. Methods: All 40 patients had chronic hepatitis C but none had hemochromatosis of a known etiology. A serum ferritin level of 10 ng/ml or less was chosen as the treatment goal, A mean blood volume of 2400+/-1100 mi was removed during treatments lasting 5+/-3 months. Results: Treatment significantly reduced the mean serum levels of alanine aminotransferase activity from 128+/-74 to 63+/-28 IU/l (p<0.01). The baseline enzyme activity was highly correlated,vith reduction in activity after treatment (r=0.94, p<0.01), but the baseline levels of ferritin and histochemistry for iron showed poor correlations with the reduction in enzyme activity (r=0.63 with p<0.01 and r=0.38 with p<0.05, respectively). Conclusions: Thus, serum levels of aminotransferases were a more important indicator for venesection than conventional indices of iron overload, probably because cytotoxic iron includes some reactive iron species rather than stored iron alone.
引用
收藏
页码:268 / 271
页数:4
相关论文
共 11 条
[1]   DIFFERENTIATION BETWEEN HETEROZYGOTES AND HOMOZYGOTES IN GENETIC HEMOCHROMATOSIS BY MEANS OF A HISTOLOGICAL HEPATIC IRON INDEX - A STUDY OF 192 CASES [J].
DEUGNIER, YM ;
TURLIN, B ;
POWELL, LW ;
SUMMERS, KM ;
MOIRAND, R ;
FLETCHER, L ;
LOREAL, O ;
BRISSOT, P ;
HALLIDAY, JW .
HEPATOLOGY, 1993, 17 (01) :30-34
[2]   MEASUREMENTS OF IRON STATUS IN PATIENTS WITH CHRONIC HEPATITIS [J].
DIBISCEGLIE, AM ;
AXIOTIS, CA ;
HOOFNAGLE, JH ;
BACON, BR .
GASTROENTEROLOGY, 1992, 102 (06) :2108-2113
[3]  
FUJIWARA K, 1990, OXFORD CLIN COMMUNIC, P28
[4]  
HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986
[5]  
Isomura Toyoshi, 1992, Journal of Clinical Electron Microscopy, V25, P231
[6]   GALLSTONE DISSOLUTION WITH URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS AND 2 YEARS FOLLOW-UP - A PILOT-STUDY [J].
LEUSCHNER, U ;
LEUSCHNER, M ;
SIERATZKI, J ;
KURTZ, W ;
HUBNER, K .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (07) :642-649
[7]  
MURRAYLYON IM, 1973, LANCET, V1, P735
[8]   IRON RELEASE FROM HEMOSIDERIN AND PRODUCTION OF IRON-CATALYZED HYDROXYL RADICALS INVITRO [J].
OZAKI, M ;
KAWABATA, T ;
AWAI, M .
BIOCHEMICAL JOURNAL, 1988, 250 (02) :589-595
[9]  
PIPERNO A, 1992, Gastroenterology, V102, pA868
[10]   LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH ALPHA-INTERFERON [J].
SHINDO, M ;
DIBISCEGLIE, AM ;
HOOFNAGLE, JH .
HEPATOLOGY, 1992, 15 (06) :1013-1016